Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease

By Feltes Timothy F   Sondheimer Henry M  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 9, 2007-09 ,pp. : 1471-1480

Informa Healthcare

Access to resources Recommend Favorite

DNA Microarray Analysis for Human Congenital Heart Disease

By Sharma Hari S.   Peters Theodorus H. F.   Moorhouse Michael J.   van der Spek Peter J.   Bogers Ad J. J. C.  

Cell Biochemistry and Biophysics, Vol. 44, Iss. 1, 2006-02 ,pp. : 1-10

Humana Press, Inc

Access to resources Recommend Favorite

Palivizumab in the prevention of respiratory syncytial virus disease

By Krilov Leonard R  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 7, 2002-10 ,pp. : 763-769

Informa Healthcare

Access to resources Recommend Favorite

Palivizumab: where to from here?

By Georgescu Georgiana   Chemaly Roy F  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 1, 2009-01 ,pp. : 139-147

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for ischemic heart disease

By Hinkel Rabea   Trenkwalder Teresa   Kupatt Christian  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 723-737

Informa Healthcare

Access to resources Recommend Favorite